158 related articles for article (PubMed ID: 25248754)
1. Role of late gadolinium enhancement cardiovascular magnetic resonance in the risk stratification of hypertrophic cardiomyopathy (HCM): but what about 'apical' HCM?
Dastidar AG; Rodrigues J; Bucciarelli-Ducci C
Heart; 2014 Dec; 100(23):1898. PubMed ID: 25248754
[No Abstract] [Full Text] [Related]
2. Sudden cardiac death prediction in hypertrophic cardiomyopathy using late gadolinium enhancement: trouble in paradise?
Jellis CL; Desai MY
Heart; 2014 Dec; 100(23):1821-2. PubMed ID: 25073886
[No Abstract] [Full Text] [Related]
3. Role of late gadolinium enhancement cardiovascular magnetic resonance in the risk stratification of hypertrophic cardiomyopathy.
Ismail TF; Jabbour A; Gulati A; Mallorie A; Raza S; Cowling TE; Das B; Khwaja J; Alpendurada FD; Wage R; Roughton M; McKenna WJ; Moon JC; Varnava A; Shakespeare C; Cowie MR; Cook SA; Elliott P; O'Hanlon R; Pennell DJ; Prasad SK
Heart; 2014 Dec; 100(23):1851-8. PubMed ID: 24966307
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy.
Green JJ; Berger JS; Kramer CM; Salerno M
JACC Cardiovasc Imaging; 2012 Apr; 5(4):370-7. PubMed ID: 22498326
[TBL] [Abstract][Full Text] [Related]
5. The value of cardiac magnetic resonance and distribution of late gadolinium enhancement for risk stratification of sudden cardiac death in patients with hypertrophic cardiomyopathy.
Klopotowski M; Kukula K; Malek LA; Spiewak M; Polanska-Skrzypczyk M; Jamiolkowski J; Dabrowski M; Baranowski R; Klisiewicz A; Kusmierczyk M; Jasinska A; Jarmus E; Kruk M; Ruzyllo W; Witkowski A; Chojnowska L
J Cardiol; 2016 Jul; 68(1):49-56. PubMed ID: 26363820
[TBL] [Abstract][Full Text] [Related]
6. Late gadolinium enhancement is common in patients with hypertrophic cardiomyopathy and no clinical risk factors for sudden cardiac death: A single center experience.
Lyons KS; Dixon LJ; Johnston N; Noad R; Hamilton A; McKeag N; Horan P
Cardiol J; 2014; 21(1):29-32. PubMed ID: 23990187
[TBL] [Abstract][Full Text] [Related]
7. Myocardial tissue characterization by gadolinium-enhanced cardiac magnetic resonance imaging for risk stratification of adverse events in hypertrophic cardiomyopathy.
Raiker N; Vullaganti S; Collins JD; Allen BD; Choudhury L
Int J Cardiovasc Imaging; 2020 Jun; 36(6):1147-1156. PubMed ID: 32166506
[TBL] [Abstract][Full Text] [Related]
8. Variables associated with contrast-enhanced cardiovascular magnetic resonance in hypertrophic cardiomyopathy: clinical implications.
Payá E; Marín F; González J; Gimeno JR; Feliu E; Romero A; Ruiz-Espejo F; Roldán V; Climent V; de la Morena G; Valdés M
J Card Fail; 2008 Jun; 14(5):414-9. PubMed ID: 18514934
[TBL] [Abstract][Full Text] [Related]
9. LGE and the risk of sudden death in HCM.
Alla VM; Koneru S; Hunter C; Mooss A
JACC Cardiovasc Imaging; 2012 Jul; 5(7):761-2; author reply 762-3. PubMed ID: 22789948
[No Abstract] [Full Text] [Related]
10. Phenotypic expression in hypertrophic cardiomyopathy and late gadolinium enhancement on cardiac magnetic resonance.
Caetano F; Botelho A; Trigo J; Silva J; Almeida I; Venâncio M; Pais J; Sanches C; Leitão Marques A
Rev Port Cardiol; 2014 May; 33(5):261-7. PubMed ID: 24909443
[TBL] [Abstract][Full Text] [Related]
11. Diffuse Ventricular Fibrosis on Cardiac Magnetic Resonance Imaging Associates With Ventricular Tachycardia in Patients With Hypertrophic Cardiomyopathy.
McLELLAN AJ; Ellims AH; Prabhu S; Voskoboinik A; Iles LM; Hare JL; Kaye DM; Macciocca I; Mariani JA; Kalman JM; Taylor AJ; Kistler PM
J Cardiovasc Electrophysiol; 2016 May; 27(5):571-80. PubMed ID: 26840595
[TBL] [Abstract][Full Text] [Related]
12. Myocardial perfusion reserve quantified by cardiac magnetic resonance imaging is associated with late gadolinium enhancement in hypertrophic cardiomyopathy.
Tezuka D; Kosuge H; Terashima M; Koyama N; Kishida T; Tada Y; Suzuki JI; Sasano T; Ashikaga T; Hirao K; Isobe M
Heart Vessels; 2018 May; 33(5):513-520. PubMed ID: 29168014
[TBL] [Abstract][Full Text] [Related]
13. Cardiac magnetic resonance imaging findings predict major adverse events in apical hypertrophic cardiomyopathy.
Hanneman K; Crean AM; Williams L; Moshonov H; James S; Jiménez-Juan L; Gruner C; Sparrow P; Rakowski H; Nguyen ET
J Thorac Imaging; 2014 Nov; 29(6):331-9. PubMed ID: 25314027
[TBL] [Abstract][Full Text] [Related]
14. Distribution of late gadolinium enhancement in end-stage hypertrophic cardiomyopathy and dilated cardiomyopathy: differential diagnosis and prediction of cardiac outcome.
Machii M; Satoh H; Shiraki K; Saotome M; Urushida T; Katoh H; Takehara Y; Sakahara H; Ohtani H; Wakabayashi Y; Ukigai H; Tawarahara K; Hayashi H
Magn Reson Imaging; 2014 Feb; 32(2):118-24. PubMed ID: 24315973
[TBL] [Abstract][Full Text] [Related]
15. Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy.
Rubinshtein R; Glockner JF; Ommen SR; Araoz PA; Ackerman MJ; Sorajja P; Bos JM; Tajik AJ; Valeti US; Nishimura RA; Gersh BJ
Circ Heart Fail; 2010 Jan; 3(1):51-8. PubMed ID: 19850699
[TBL] [Abstract][Full Text] [Related]
16. Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy: comparison of diagnostic performance in myocardial fibrosis between gadobutrol and gadopentetate dimeglumine.
Liu D; Ma X; Liu J; Zhao L; Chen H; Xu L; Sun Z; Fan Z
Int J Cardiovasc Imaging; 2017 Aug; 33(8):1191-1200. PubMed ID: 28289991
[TBL] [Abstract][Full Text] [Related]
17. Use of cardiovascular magnetic resonance for diagnosis and management in hypertrophic cardiomyopathy.
O'Hanlon R; Assomull RG; Prasad SK
Curr Cardiol Rep; 2007 Mar; 9(1):51-6. PubMed ID: 17362685
[TBL] [Abstract][Full Text] [Related]
18. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance.
Moon JC; McKenna WJ; McCrohon JA; Elliott PM; Smith GC; Pennell DJ
J Am Coll Cardiol; 2003 May; 41(9):1561-7. PubMed ID: 12742298
[TBL] [Abstract][Full Text] [Related]
19. [Clinical significance of late gadolinium enhancement on cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy].
Dumont CA; Monserrat L; Soler R; Rodríguez E; Fernández X; Peteiro J; Bouzas B; Piñón P; Castro-Beiras A
Rev Esp Cardiol; 2007 Jan; 60(1):15-23. PubMed ID: 17288951
[TBL] [Abstract][Full Text] [Related]
20. Magnetic resonance imaging of hypertrophic cardiomyopathy.
Cannavale A; Ordovás KG; Higgins CB
J Thorac Imaging; 2013 Jan; 28(1):W12-8. PubMed ID: 20827222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
